April 19, 2016| The Trendlines Group, an Israeli innovation commercialization company, and the CropScience division of Bayer AG announced Monday that they had signed an agreement to form a $10-million venture capital fund to invest in early-stage agrotechnology startups and other companies of interest to the German pharmaceuticals and agrochemicals giant. The capital for the Bayer Trendlines Agtech Innovation Fund will come from Bayer and be allocated over the next five years; Trendlines will manage the portfolio. The partnership couples Bayer’s decades of experience in agricultural science, innovation and regulatory affairs with Trendlines’ specialization in investing in cutting-edge, early-stage medical and agricultural technologies. Based in the Israeli town of Migav and traded on the Singapore Exchange, Trendlines invests in medical and agricultural technologies.
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors

Ashdod Port Investing In Startups As Part Of Innovation Strategy

Facebook comments